HF 2024 Premium Access

Initiation of sodium-glucose co-transporter-2 inhibitors in patients with heart failure in the acute medical setting

Congress Presentation

About the speaker

Doctor Tjasa Furlan

Trbovlje General Hospital, Trbovlje (Slovenia)
0 follower

7 more presentations in this session

Medication optimisation after acute heart failure hospitalisation: a current situation in a developing country

Speaker: Doctor K. Lorlowhakarn (Bangkok, TH)

Thumbnail

Applicability of vericiguat in heart failure patients early post-discharge: a single-center study

Speaker: Doctor M. Passos (Amadora, PT)

Thumbnail

Impact of statins on mortality and re-hospitalization in acute heart failure patients

Speaker: Doctor R. Rajan (Kuwait, KW)

Thumbnail

The eligibility of patients hospitalized for heart failure for rapid up-titration of guideline-directed medical therapy in the light of the STRONG-HF trial and the latest ESC heart failure guidelines

Speaker: Doctor F. Banfi-Bacsardi (Budapest, HU)

Thumbnail

Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on hypotension, titration and drug combination

Speaker: Doctor M. Chou (Tainan, TW)

Thumbnail

Access the full session

ePosters in chronic heart failure - pharmacotherapy 4

Speakers: Doctor T. Furlan, Doctor K. Lorlowhakarn, Doctor M. Passos, Doctor R. Rajan, Doctor F. Banfi-Bacsardi...
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb